January 24, 2024 : Siemens Healthineers and the Indian Institute of Science (IISc) have opened the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory for AI in Precision Medicine at IISc Bangalore today.
Peter Schardt, Chief Technology Officer of Siemens Healthineers, inaugurated this state-of-the-art laboratory. The CDS collaborative laboratory will develop open-source AI-based tools to precisely automate the segmentation of pathological findings in neuroimaging data, with a focus on accurately diagnosing neurological diseases and analyzing their clinical impact at a population level.
The laboratory has been established with the support of Siemens Healthineers Corporate Social Responsibility initiative, which also includes six M.Tech fellowships for women, aiming to enhance female representation in artificial intelligence.
Dr. Vaanathi Sundaresan of IISc's Department of CDS will lead the programme. The focus of this collaborative laboratory will be to work closely with neurologists, radiologists and Siemens Healthineers and integrate the developed computational models into their regular clinical workflows.
Said Peter Schardt: “The collaboration with IISc solidifies our commitment to advancing precision medicine through AI using state-of-the-art, data-driven deep-learning techniques. Leveraging IISc's academic excellence and our strong core in medical imaging, smart solutions developed through this collaboration will help us ultimately save lives through precise diagnoses and evidence-based treatments”.
Prof Govindan Rangarajan, Director, Indian Institute of Science, said, “This lab marks a crucial step forward in unlocking the potential of AI for precision medicine. Together, we are accelerating the future of healthcare for everyone. This collaboration is a powerful example of how industry and academia can come together to tackle complex challenges."
Dileep Mangsuli, Executive Director, Siemens Healthineers, said “India is one of the four global innovation hubs for Siemens Healthineers, and we are committed to being catalysts in interdisciplinary research. This laboratory is a part of our CSR initiative. We take pride in giving back to the society and healthcare research is an important aspect of it. Along with IISc, we aim to reshape the landscape of neuroscientific progress through the capabilities of artificial intelligence, translating laboratory insights into intelligent solutions. We want to empower the broader clinical research community and be changemakers in the fight against world’s most life-threatening diseases.”